SEQUOIA-HCM Substudy Details Effects of Aficamten on Cardiac Structure and Remodeling
Ahmad Masri, MD, MS, discusses the results of a SEQUOIA-HCM substudy leveraging cardiac magnetic resonance to assess structural changes associated with aficamten use in HCM.
ESC Congress Study Highlights Safety of Aficamten in Hypertrophic Cardiomyopathy
Ahmad Masri, MD, MS, discusses an integrated safety analysis of aficamten using data from 3 clinical trials.
Siddharth Patel, MD, MPH: Abelacimab Could Help Reduce Procedure-Related Bleeding
Siddharth Patel, MD, MPH, discusses how an AZALEA-TIMI 71 analysis presented at ESC Congress 2024.
Kausik Ray, MD, MPhil: INTERASPIRE and the Expanding Knowledge Base for Lipoprotein(a)
Kausik Ray, MD, MPhil, discusses the results of the INTERASPIRE study and how it improves our understanding of the effects of elevated Lp(a).
Rahul Aggarwal, MD: Sotagliflozin Benefit Grows with Increasing Diabetes Duration
Rahul Aggarwal, MD, discusses the findings of a SCORED analysis examining sotagliflozin's effects based on diabetes duration.
FLOW: Semgalutide Provides Consistent CV Benefit Across Spectrum of Kidney Disease
Kenneth Mahaffey, MD, discusses FLOW trial data showing semaglutide improves cardiovascular outcomes in patients with type 2 diabetes, regardless of CKD severity.
In Women, History of Cancer Linked to Subclinical Atherosclerosis
Sara Diaz Saravia, MD, discusses a study from ESC Congress 2024 examining the utility of cancer history in women as a predictor of subclinical atherosclerosis.
Common Pitfalls to Avoid When Interpreting Clinical Trials, with Deepak Bhatt, MD, MPH, MBA
Deepak Bhatt, MD, MPH, MBA, discusses common pitfalls for clinicians when interpreting trial data based on a presentation he led at ESC Congress 2024.
Philip Mease, MD: Bimekizumab’s Efficacy Over Ustekinumab, Risankizumab in Treating PsA, AxSpA
Mease discussed data supporting FDA approval for the indications in Fall 2024.
ESC Congress 2024 Lipidology Preview, with Professor Kausik Ray
Kausik Ray, MD, discusses what trials and new data in lipidology he is most looking forward to from the upcoming ESC Congress.
Discussing Use of Vaping Among Students, Conversations About Vaccines
During this segment of a recent Lungcast, Mora and Sadeameli speak about 2 key topics: vaping and e-cigarette use among children as well as vaccinations and related misinformation.
Laurence Sperling, MD: Navigating the Changing Landscape of Lipidology
Laurence Sperling, MD, offers perspective on multiple topics within the evolving field of lipid management and dyslipidemia.
Allergies and Asthma During the School Year, with S. Christy Sadeameli, MD, and Juanita Mora, MD
In this Lungcast episode, Mora and Sadeameli highlight Asthma Action Plans as well as Asthma Peak Weak considerations for children in the new school year.
Gil Yosipovitch, MD: Next Steps Following FDA Approval of Nemolizumab for Prurigo Nodularis
Yosipovitch spoke in this interview about the clinical trials leading up to the FDA approval of his nemolizumab for patients with prurigo nodularis.
What the FDA Approval of Nemolizumab Means for Prurigo Nodularis, with Gil Yosipovitch, MD
In this interview, Yosipovitch discusses his team’s findings on nemolizumab and the significance of the drug’s FDA approval for those with prurigo nodularis.
ESC Congress 2024 Clinical Trials to Watch, with Deepak Bhatt, MD, MPH, MBA
Deepak Bhatt, MD, MPH, MBA, discusses 7 trials to watch from hotline or late-breaking sessions at the upcoming European Society of Cardiology Congress 2024.
Impact of Nasal Epinephrine Spray for Patients with Severe Allergies, with Edwin H. Kim, MD
In this interview, Kim speaks about the significance of the FDA approval of neffy for patients who face the threat of anaphylaxis and other severe allergic reactions.
Discussing the Global Prevalence of Seborrheic Dermatitis, with Raj Chovatiya, MD, PhD
In this interview, Chovatiya spoke with the editorial team about the global prevalence findings on patients with seborrheic dermatitis and their implications.
Casey Paleos, MD: Remaining Questions on MDMA-Assisted Therapy in PTSD
In this video series segment, Casey Paleos, MD, provides insight into what he considers to be the most pertinent unanswered questions surrounding MDMA-assisted therapy in PTSD.
Casey Paleos, MD: Potential of Psychedelic Therapies in PTSD Management
In this video series segment, Casey Paleos, MD, discusses his outlook on the potential of psychedelic therapies in PTSD looking forward.
Casey Paleos, MD: Confronting Stigma Associated with MDMA in Therapeutic Context
In this video series segment, Casey Paleos, MD, offers insight into the impact of historic stigma associated with psychedelic therapies on acceptance in psychiatric care.
Casey Paleos, MD: Interpreting Trial Data and Safety for MDMA-Assisted Therapy in PTSD
In this video series segment, Casey Paleos, MD, describes his interpretation of clinical trial data for MDMA-assisted therapy in PTSD as well as his reaction to the FDA PDAC vote in early June.
Casey Paleos, MD: Current Options and Unmet Need in PTSD
In this video series segment, Casey Paleos, MD, provides perspective on the current options and unmet needs in the management of posttraumatic stress disorder.
Brett King, MD, PhD: Value of LEVEL UP Data and Pushing New Standards in Dermatology
Brett King, MD, PhD, discusses the LEVEL UP trial and how it represents the field of dermatology's desire to advance care and advocate for new standards of care.
Janelle Bludhorn, MS, PA-C: How Common Medications Are Impacted by Extreme Heat
This segment of the latest Lungcast featured a discussion about heat and its interplay with various types of common medications.
Jonathan Silverberg, MD, PhD: Treatment Modification Following New Recommendations for Eczema
This interview segment featured Silverberg discussing the AHEAD atopic dermatitis recommendations and their implications for clinicians and patients.
Updates to International Recommendations for Eczema, with Jonathan Silverberg, MD, PhD
Silverberg discusses the new AHEAD recommendations for optimizing atopic dermatitis management, highlighting goals, disease severity assessments, and guidance for escalation.
How to Screen for Heat-Related Illness Risks, with Janelle Bludorn, MS, PA-C
In this Lungcast segment, Bludorn speaks on commonly-seen heat-related illnesses amid a changing climate as well as how to screen for related risks.
Melinda Gooderham, MD: Effects of Roflumilast Foam on Scalp, Body Psoriasis
In this interview, Gooderham highlights the ARRECTOR study findings which led to roflumilast foam’s supplemental new drug application to the FDA.
HCPLive Five at ASRS 2024
Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key interviews from the American Society of Retina Specialists (ASRS) 42nd Annual Meeting.